Agree, where forward means higher. After decades of CNS research/treatment misses investors are CNS PTSD wasted. When news that looks at least OK comes along reactions are muted and erratic. Who can blame them.
Well, it's time to move forward and up w/conviction using data and information from multiple sources (peer reviewed AD pub, PDD trial information, RSD trial information, AD historical reviews, AD new trial information, and more).
AVXL has to do a bootstrap exercise since the previously used FDA new information/trials based context has pretty much self imploded for now. Never seen anything quite like it. News will not travel in a vacuum so we are going to have to be really strong to get attention.
"We should be moving forward from here,"--also agree---where I come from the markets are forward looking (meaning how are the prospects for a co.in the future)--looking down the road. For Anavex--lots of good things will be happening--the markets are (should be) aware of these events and price the stock accordingly. Time to get this priced correctly from our grossly undervalued price---look forward market--big news on the horizon !!!!!!
News 
Market Data 
Discover 
